Michalis Karamouzis

Dr. Karamouzis is Medical Oncologist, Professor in National and Kapodistrian University of Athens. He is working in Eugenidion Hospital, treating patients with gastrointestinal malignant tumors. 
Besides his clinical work he has organized a Molecular Oncology Unit. He has established a strong research program and created a highly skilled and competent research group. He has also formed collaborations with well-established cancer research scientists. Prof. Karamouzis' lab advanced in the proximity ligation assay technique that can evaluate dimerization of two proteins as well as enhance the signal of low abundant proteins in situ. Additionally, his team is working on improving immunotherapy result and identifying predictive biomarkers in aerodigestive carcmomas. 
Prof. Michalis Karamouzis' national and international recognition counts 31 communications in International conferences and 36 in National conferences. He has participated in 18 round tables and was invited and gave 15 lectures in National conferences. He has more than 120 publications in international peer-reviewed journals listed in SCI which a mean impact factor of 8.1. His publications have achieved until now more than 16.000 citations. The H-index is 41. 
Prof Karamouzis has also served as a reviewer for many peer-reviewed international journals (such as Ann Oncol, J Clin Oncol, Breast Cancer Res, EurJ Cancer, Lancet Oncol, Cancer Metastasis Rev, and many others). He has also served as an evaluator of scientific project proposals, both national and international. 
In the context of the educational proceedings, Prof. Michael Karamouzis teaches in two undergraduate courses in Athens Medical School and Dental School on Biological Chemistry. His main teaching course is carcinogenesis and the impact of various signal transduction pathways in the initiation and progression of malignant tumors. 
He is an active ESMO Member, past chair of ESMO Young Oncologists Committee and has participated in various ESMO groups, among then Publication Working Group in which he was one of the Editors of the latest ESMO Essentials for Clinicians on Gastrointestinal Cancers.